Dr. Altaf Bhat, a faculty member at the Centre for Interdisciplinary Research and Innovations (CIRI) at the University of Kashmir (KU), has secured a prestigious research grant worth approximately ₹1.5 crore from the Lady Tata Memorial Trust.
The grant will support Dr. Bhat’s project, which focuses on studying the role of chromatin modifiers in regulating 3D genome organization during leukemia.
This groundbreaking research aims to uncover new insights and develop efficient therapeutic strategies for the disease.
KU Vice-Chancellor Prof. Nilofer Khan congratulated Dr. Bhat on the achievement, highlighting its significance in enhancing the university’s reputation as a leading center for interdisciplinary research.
“CIRI is steadily evolving into a world-class research hub, contributing substantially to the academic and research excellence of our institution,” she remarked.
Prof. Khan also emphasized the value of the state-of-the-art instrumentation facilities established at CIRI, which not only improve research quality but also provide essential training opportunities for students.
“Such advancements elevate the university’s standing at both national and international levels,” she added.
This grant marks a significant milestone for the University of Kashmir, reaffirming its commitment to advancing scientific research and addressing critical health challenges.